共 113 条
[1]
Loddo I(2015)Inflammatory bowel disease: genetics, epigenetics, and pathogenesis Front Immunol 6 551-972
[2]
Romano C(2017)The incidence of inflammatory bowel disease in Denmark 1980–2013: a nationwide cohort study Aliment Pharmacol Ther 45 961-28
[3]
Lophaven SN(2012)Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 e42-72
[4]
Lynge E(2006)Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation Gastroenterology. 131 719-222
[5]
Burisch J(2015)Iron deficiency anemia in inflammatory bowel disease World J Gastrointest Pathophysiol 6 62-1318
[6]
Molodecky NA(2015)European Crohn’s and Colitis Organisation [ECCO]. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases J Crohns Colitis 9 211-509
[7]
Soon IS(2017)Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease Aliment Pharmacol Ther 45 1303-1192
[8]
Rabi DM(2011)Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice Ther Clin Risk Manag 7 501-360
[9]
Odes S(2015)Intravenous iron therapy in patients with iron deficiency anemia: dosing considerations Anemia 2015 763576-161
[10]
Vardi H(2008)A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial Am J Gastroenterol 103 1182-1446